MedRhythms
Portland, Maine, United States · Biotechnology, Information Technology
MedRhythms is a digital therapeutics company that uses sensors, music and software to build evidence-based neurologic interventions to measure and improve walking. The Company’s product pipeline consists of multiple clinical programs for neurologic conditions, the most advanced are in chronic stroke, multiple sclerosis, and Parkinson’s disease. MedRhythms was founded out of Spaulding Rehabilitatio
Key facts
- Headquarters
- Portland, Maine, United States
- Employees
- 26
- Industries
- Biotechnology, Information Technology
- Status
- Private
- Website
- www.medrhythms.com
- Company page
Recent activity at MedRhythms
- : MedRhythms
- : MedRhythms
- : MedRhythms
- : MedRhythms Appoints Larry Jasinski as Chief Executive Officer
- : MedRhythms
- : MedRhythms Hires Joel Behnke as Chief Commercial Officer
- : MedRhythms, Inc. Launches InTandem® Rehabilitation System for Chronic Stroke Gait Impairment, Receiving Medicare Payment Determination.
- : MedRhythms
- : MedRhythms
- : MedRhythms
MedRhythms funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Venture | $250K |
| Aug 2026 | Series B | $1.0M |
| Mar 2026 | Series B | $3.3M |
| Apr 2025 | Series B | $2.9M |
| Dec 2023 | Venture | $19.0M |
Leadership
- Brian Harris, Executive Officer, Director
- Owen McCarthy, Executive Officer, Director
- Peter Werth, Director
- Raymond Pawlicki, Director
- Jean Hoffman, Director
- Larry Jasinski, Chief Executive Officer
Verified email and direct lines for MedRhythms’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
MedRhythms files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
MedRhythms in the news
- MedRhythms and Edwards Health Care Services, a GEMCORE Family Company, Enter into National Distribution Agreement - PR Newswire (Sep 16, 2025)
- Biogen grabs MS music therapy from MedRhythms in $120m deal - pharmaphorum (May 06, 2022)
- Brian Harris of MedRhythms: Five Things You Need To Be A Highly Effective Leader During Turbulent… - Medium (Jan 26, 2021)
- MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic - PR Newswire (Jun 15, 2020)
- Revealed: The Health Tech World Top 50 Innovators of 2022 - Health Tech World (Aug 08, 2022)
- MedRhythms Announces New CMS Reimbursement Code for InTandem® Rehabilitation System For Chronic Stroke Gait Impairment - PR Newswire (Aug 22, 2024)
- MedRhythms Announces FDA Class II Listing for Movive™ to Support Gait Rehabilitation and Motor Function for Parkinson's Disease - PR Newswire (Mar 06, 2025)
- MedRhythms Announces Availability of Movive™ for Parkinson's Disease (PD) for Veterans - PR Newswire (Apr 02, 2025)
Companies similar to MedRhythms
- Respiree · Biotechnology, Information Technology
- Outcomes4Me · Biotechnology, Information Technology
- Cyrus Biotechnology, Inc. · Biotechnology, Information Technology
- Aduro Clean Technologies · Biotechnology, Information Technology
- Ebenbuild · Biotechnology, Information Technology
About MedRhythms: questions and answers
What does MedRhythms do?
MedRhythms is a digital therapeutics company that uses sensors, music and software to build evidence-based neurologic interventions to measure and improve walking. The Company’s product pipeline consists of multiple clinical programs for neurologic conditions, the most advanced are in chronic stroke, multiple sclerosis, and Parkinson’s disease. MedRhythms was founded out of Spaulding Rehabilitatio
Where is MedRhythms headquartered?
MedRhythms is headquartered in Portland, Maine, United States.
How many employees does MedRhythms have?
MedRhythms has about 26 employees.
Has MedRhythms raised funding?
Yes. Fundz has recorded 5 funding events for MedRhythms. The most recent, $250K, was in Oct 2026.
Who leads MedRhythms?
Larry Jasinski is a Chief Executive Officer at MedRhythms.
What is the latest news on MedRhythms?
On Oct 13, 2026, MedRhythms
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy